EZH2 and breast cancer: H3K27me3 expression was lowest in more aggressive subtypes of breast cancer, specifically the basal-like, triple negative, luminal B, and ER-positive tumors with high proliferation index, similar to EZH2 which was highest in basal-like and triple negative tumors [57].